Anthropic Pitches Congress Its Own AI Safety Bill

Anthropic has been actively lobbying members of Congress with a draft AI safety bill of its own design, according to a report from Mashable citing sources familiar with the effort. The move puts the Claude-maker at the center of what is becoming an increasingly crowded race among technology companies to influence the shape of federal AI legislation before Washington moves on its own terms.

What Anthropic Is Proposing

Details of the bill's full text have not been made public, but the lobbying push reflects a broader strategy by Anthropic to engage policymakers directly rather than react to regulations written without industry input. The company has long argued that frontier AI development requires specific safety standards that generic technology rules may not address. Pitching its own draft legislation is a way to ensure those standards are baked into any eventual framework from the start.

The timing is notable. Congress has struggled to produce cohesive AI legislation despite years of hearings and discussion. In that vacuum, Anthropic's quiet pitch to lawmakers could gain traction simply by offering a concrete starting point. Legislators looking for a framework to work from may find it easier to amend an existing draft than to build one from scratch, which is exactly the kind of influence a company in Anthropic's position would want to establish early.

Anthropic has consistently argued that the most dangerous AI risks require proactive safeguards, not reactive ones. Bringing a bill directly to Congress is consistent with that posture.Analysis based on company public statements

Get the Claude AI Handboek

458 pages on getting more out of Claude, by AI expert Leon Tindemans. A printed book, written in Dutch, shipped worldwide with track and trace.

View the book →

Anthropic's Broader Safety Stance

This lobbying effort fits a pattern. Anthropic has previously joined other AI executives in urging Congress to act on specific threats, including calls to screen synthetic DNA orders as AI models approach PhD-level capabilities in biology. The company's leadership has also been vocal in public forums about existential risk, with Dario and Daniela Amodei discussing AI extinction scenarios in high-profile settings. Advocating for legislation is a natural extension of that public posture.

Critics may argue that a company drafting the very regulations meant to govern it creates an obvious conflict of interest. The concern is not abstract: self-authored regulatory frameworks have historically tended to favor incumbents and raise barriers for smaller competitors. Whether Anthropic's proposal genuinely prioritizes public safety or competitive positioning will depend heavily on the specifics that emerge if and when the draft becomes public.

At the same time, Anthropic has accompanied its own model releases with explicit safety warnings, suggesting the company is at least willing to publicly acknowledge the risks of its own products. That credibility may give its legislative pitch more weight on Capitol Hill than similar efforts from companies with thinner safety records.

For now, the lobbying campaign adds another layer to an already complex regulatory environment. Federal AI legislation remains stalled, state-level efforts vary widely, and the industry continues to advance faster than lawmakers can study it. Whether Anthropic's bill gains real traction or simply shapes the conversation at the margins, the company has made clear it intends to be at the table when the rules are written.